KalVista Pharmaceuticals (KALV) Cash & Equivalents Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 48.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 48.62% |
| Apr 30, 2025 | 62.39% |
| Oct 31, 2024 | -3.65% |
| Jul 31, 2024 | -12.99% |
| Apr 30, 2024 | -14.35% |
| Jan 31, 2024 | 9.16% |
| Oct 31, 2023 | 52.77% |
| Jul 31, 2023 | 39.98% |
| Apr 30, 2023 | 52.72% |
| Jan 31, 2023 | 65.93% |
| Oct 31, 2022 | 21.11% |
| Jul 31, 2022 | 7.94% |
| Apr 30, 2022 | -1.34% |
| Jan 31, 2022 | -6.83% |
| Oct 31, 2021 | -27.32% |
| Jul 31, 2021 | 0.19% |
| Apr 30, 2021 | -0.30% |
| Jan 31, 2021 | -32.90% |
| Oct 31, 2020 | -16.84% |
| Jul 31, 2020 | -12.02% |
| Apr 30, 2020 | -20.10% |
| Jan 31, 2020 | -17.79% |
| Oct 31, 2019 | 26.67% |
| Jul 31, 2019 | 24.43% |